Skip to main content

CapForce Inc.

CFOR
Exchange
OTC
Industry
Services-Medical Laboratories
SEC CIK
0001293818

No open-market purchases or sales by CapForce Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding CapForce Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of CFOR: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders711−5
Shares4.76K1.59K3−3.16K (−99.9%)
Value$12.3K$4.12K$6−$8.15K (−99.9%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (1)

Institutions that held CapForce Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to CFOR in Q3 2024
InstitutionSharesValue% of portfolio
Jones Financial Companies LLLP3$60.00%

Sold out (6)

Institutions that held CapForce Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of CFOR in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Tower Research Capital LLC (TRC)1,823$4.70K
UBS Group AG1,245$3.21K
Qube Research & Technologies Ltd80$207
Bank of America Corp9$24
GWM Advisors LLC5$13
Royal Bank of Canada5$0

Not filed for Q3 2024 yet (1)

Institutions that held CapForce Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CFOR in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.1,595$4.12K